Safety and Efficacy of Eribullin or Eribulin Combined With Anlotinib in Metastatic Breast Cancer
Clinical trial NCT05206656 · COMPLETED
Trial details
- NCT number
- NCT05206656
- Sponsor
- Hunan Cancer Hospital
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-09
- Primary completion
- 2022-04-30
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.